TrialJAMA network open2023

Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset: A Phase 3 Randomized Clinical Trial.

Haiqing Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.